New data showed childhood obesity has hit a record high in recent years, while federal changes such as cuts to food ...
In recent years, rates of childhood obesity have been rising, with the U.S. Centers for Disease Control estimating in 2024 ...
With semaglutide patent ending, Indian pharma firms are set to launch lower-cost versions, prompting hospitals and clinics to expand obesity services ahead of a surge in demand.
The generic versions of semaglutide are expected to be at least 50% cheaper— ₹5,000 for a weekly dose—than Ozempic in India .
"Without Medi-Cal, there is no way I can afford Wegovy or any alternative on my own." ...
A new WalletHub study ranks the most overweight and obese cities in the US. See where six California city rank on the list.
Early intervention in childhood obesity can significantly reduce future health risks and promote sustainable weight management before age ten.
Everyday Health on MSN
GLP-1 and exercise 101: A beginner-friendly approach to staying strong during weight loss
GLP-1 and exercise don't have to feel overwhelming. Learn how to move safely, build strength, and support long-term results.
A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management programs that offer beneficial ...
Some are afraid to move if it hurts. Some push too hard. Everyone agrees that exercise reduces chronic pain and enhances health — but how do you keep patients on track?
NDTV Profit on MSN
Ozempic Patent Expiry Heralds Weight-Loss Drug Boom In India
Startups are also positioning themselves. New Delhi-based Enlighten Now Healthcare Pvt., which operates weight management platform Elevate Now, is adding corporate partnerships, tying up with large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results